Cargando…
HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
There are at least two reasons why health technology assessment (HTA) agencies need to seek process-based solutions to support the legitimacy of healthcare resource allocation, ie, (i) in pluralistic societies, the existence of often conflicting and incommensurable claims (ie, the "fragmentatio...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kerman University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947902/ https://www.ncbi.nlm.nih.gov/pubmed/32610783 http://dx.doi.org/10.34172/ijhpm.2020.22 |
_version_ | 1783663324346449920 |
---|---|
author | Schlander, Michael |
author_facet | Schlander, Michael |
author_sort | Schlander, Michael |
collection | PubMed |
description | There are at least two reasons why health technology assessment (HTA) agencies need to seek process-based solutions to support the legitimacy of healthcare resource allocation, ie, (i) in pluralistic societies, the existence of often conflicting and incommensurable claims (ie, the "fragmentation of value") and the lack of a broadly accepted, ethically defensible analytical framework, and (ii) the well-documented loopholes of the conventional logic of cost-effectiveness (CE) with its reductionist concept of allocative efficiency, which fails to reflect the distributive dimension of resource allocation decisions in collectively financed health schemes. |
format | Online Article Text |
id | pubmed-7947902 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Kerman University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-79479022021-03-16 HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe" Schlander, Michael Int J Health Policy Manag Commentary There are at least two reasons why health technology assessment (HTA) agencies need to seek process-based solutions to support the legitimacy of healthcare resource allocation, ie, (i) in pluralistic societies, the existence of often conflicting and incommensurable claims (ie, the "fragmentation of value") and the lack of a broadly accepted, ethically defensible analytical framework, and (ii) the well-documented loopholes of the conventional logic of cost-effectiveness (CE) with its reductionist concept of allocative efficiency, which fails to reflect the distributive dimension of resource allocation decisions in collectively financed health schemes. Kerman University of Medical Sciences 2020-02-19 /pmc/articles/PMC7947902/ /pubmed/32610783 http://dx.doi.org/10.34172/ijhpm.2020.22 Text en © 2021 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Schlander, Michael HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe" |
title | HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe" |
title_full | HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe" |
title_fullStr | HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe" |
title_full_unstemmed | HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe" |
title_short | HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe" |
title_sort | hta agencies need evidence-informed deliberative processes comment on "use of evidence-informed deliberative processes by health technology assessment agencies around the globe" |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947902/ https://www.ncbi.nlm.nih.gov/pubmed/32610783 http://dx.doi.org/10.34172/ijhpm.2020.22 |
work_keys_str_mv | AT schlandermichael htaagenciesneedevidenceinformeddeliberativeprocessescommentonuseofevidenceinformeddeliberativeprocessesbyhealthtechnologyassessmentagenciesaroundtheglobe |